Verucerfont

CAS No.

885220-61-1

MDL No.

MFCD19443727

C₂₂H₂₆N₆O₂

406.50

InChI Key

VKHVAUKFLBBZFJ-SFHVURJKSA-N

Pack Size	Purity	Price	Availability
1 mg	≥99%	$68	In Stock
5 mg	≥99%	$237	In Stock
10 mg	≥99%	$380	In Stock
25 mg	≥99%	$756	In Stock
50 mg	≥99%	$1207	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

1 mg

≥99%

$68

In Stock

5 mg

≥99%

$237

In Stock

10 mg

≥99%

$380

In Stock

25 mg

≥99%

$756

In Stock

50 mg

≥99%

$1207

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	885220-61-1
Product Name	Verucerfont

Biological Targets

CRHR1

Associated Conditions

alcohol dependence·congenital adrenal hyperplasia·irritable bowel syndrome·post-traumatic stress disorder·social anxiety disorder·

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Documentation

Verucerfont

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Related Articles

The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects.

Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.

Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic properties.

[Prognosis of the acute episode in renal insufficiency].

Documentation